| scholarly article | Q13442814 |
| P50 | author | Evgeni V Sokurenko | Q87688229 |
| James R Johnson | Q89498724 | ||
| Michael A Kuskowski | Q114309287 | ||
| Veronika Tchesnokova | Q116019136 | ||
| P2093 | author name string | Brian Johnston | |
| P2860 | cites work | Interplay in the selection of fluoroquinolone resistance and bacterial fitness | Q28475870 |
| Sex and virulence in Escherichia coli: an evolutionary perspective | Q28768050 | ||
| Pandemic lineages of extraintestinal pathogenic Escherichia coli. | Q30361717 | ||
| Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain | Q30396308 | ||
| Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage | Q33798233 | ||
| The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients | Q33964949 | ||
| Escherichia coli ST131, an intriguing clonal group | Q34057648 | ||
| The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities | Q34431394 | ||
| Active efflux, a common mechanism for biocide and antibiotic resistance | Q34631443 | ||
| Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem | Q35124037 | ||
| Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme | Q35127937 | ||
| Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli | Q35631010 | ||
| High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli | Q35804735 | ||
| Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. | Q36048167 | ||
| Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments | Q36105056 | ||
| Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections | Q36505534 | ||
| Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli | Q36607290 | ||
| Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome | Q37125099 | ||
| Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans | Q37220795 | ||
| Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004 | Q37247793 | ||
| The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx | Q37408471 | ||
| Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. | Q37671098 | ||
| Global dissemination of a multidrug resistant Escherichia coli clone | Q37711903 | ||
| Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates | Q38492237 | ||
| Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage | Q38848662 | ||
| Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings | Q39485718 | ||
| Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Escherichia coli | Q39801923 | ||
| Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. | Q40028752 | ||
| Quinolone-resistant Escherichia coli isolated from birds of prey in Portugal are genetically distinct from those isolated from water environments and gulls in Portugal, Spain and Sweden | Q40137027 | ||
| In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates | Q41623941 | ||
| Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates | Q41810485 | ||
| Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. | Q42872176 | ||
| Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States | Q43007779 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010. | Q50886232 | ||
| Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli. | Q52247046 | ||
| Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE. | Q54327553 | ||
| Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates. | Q54372087 | ||
| Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections. | Q54377726 | ||
| Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations | Q79812076 | ||
| P2507 | corrigendum / erratum | Erratum for Johnson et al., intensity and mechanisms of fluoroquinolone resistance within the H30 and H30Rx subclones of Escherichia coli sequence type 131 compared with other fluoroquinolone-resistant E. coli | Q42546075 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 4471-4480 | |
| P577 | publication date | 2015-05-18 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli | |
| P478 | volume | 59 |
| Q28551202 | A Transporter Interactome Is Essential for the Acquisition of Antimicrobial Resistance to Antibiotics |
| Q89498728 | Activity of ceftolozane-tazobactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status |
| Q90167602 | Activity of imipenem/relebactam against carbapenem-resistant Escherichia coli isolates from the United States in relation to clonal background, resistance genes, co-resistance, and region |
| Q33601780 | Analysis of Serial Isolates of mcr-1-Positive Escherichia coli Reveals a Highly Active ISApl1 Transposon |
| Q36325629 | Bacterial clonal diagnostics as a tool for evidence-based empiric antibiotic selection |
| Q37134169 | CIPROFLOXACIN RESISTANCE PATTERN AMONG BACTERIA ISOLATED FROM PATIENTS WITH COMMUNITY-ACQUIRED URINARY TRACT INFECTION |
| Q58781056 | Characterizing Mobilized Virulence Factors and Multidrug Resistance Genes in Carbapenemase-Producing in a Sri Lankan Hospital |
| Q64267770 | Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains |
| Q26741585 | Dissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant Bacteria |
| Q46237911 | Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria |
| Q42386431 | Editorial: Alternative Therapeutics against MDR Bacteria - "Fighting the Epidemic of Antibiotic Resistance". |
| Q90218796 | Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents |
| Q30378612 | Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131. |
| Q37120155 | Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans |
| Q47110796 | Molecular Characteristics of ST1193 Clone among Phylogenetic Group B2 Non-ST131 Fluoroquinolone-Resistant Escherichia coli |
| Q64063220 | Molecular and Physiological Characterization of Fluoroquinolone-Highly Resistant Enteritidis Strains |
| Q61805104 | Multidrug-Resistant Complex Emerging as a Global, Diversifying Threat |
| Q53694305 | Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli. |
| Q30397339 | Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance |
| Q47123962 | Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital |
| Q30386217 | The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts. |
| Q57035779 | The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131 |
| Q36324271 | The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone |
| Q28550451 | The Widespread Presence of a Multidrug-Resistant Escherichia coli ST131 Clade among Community-Associated and Hospitalized Patients |
| Q89915169 | Zinc can counteract selection for ciprofloxacin resistance |
| Q42546075 | Erratum for Johnson et al., intensity and mechanisms of fluoroquinolone resistance within the H30 and H30Rx subclones of Escherichia coli sequence type 131 compared with other fluoroquinolone-resistant E. coli | main subject | P921 |
Search more.